Diacylglycerol Signaling

More documents

Recommendations

Info

378 J. Kim and M.G. Kazanietz Xu, H., Czerwinski, P., Hortmann, M., Sohn, H. Y., Forstermann, U., & Li, H. (2008). Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovascular Research, 78(2), 349–355. Yin, Y. J., Salah, Z., Maoz, M., Ram, S. C., Ochayon, S., Neufeld, G., et al. (2003). Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB Journal, 17(2), 163–174. Zeng, Z. Z., Jia, Y., Hahn, N. J., Markwart, S. M., Rockwood, K. F., & Livant, D. L. (2006). Role of focal adhesion kinase and phosphatidylinositol 3’-kinase in integrin fibronectin receptormediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Research, 66(16), 8091–8099. Zhang, J., Park, S. I., Artime, M. C., Summy, J. M., Shah, A. N., Bomser, J. A., et al. (2007). AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. The Journal of Clinical Investigation, 117(10), 2962–2973.
Page 2:
Current Cancer Research For other t
Page 8:
Editor Marcelo G. Kazanietz, Ph.D.
Page 14:
Contents Part I Regulation of PKC I
Page 18:
Contents 21 PKC and Resistance to C
Page 24:
xii Contributors Maria T. Diaz-Meco
Page 28:
xiv Contributors Lauren Van Wassenh
Page 32:
Chapter 1 Protein Kinase C in Cance
Page 36:
1 Protein Kinase C in Cancer Signal
Page 40:
1 Protein Kinase C in Cancer Signal
Page 44:
Chapter 2 Regulation of Conventiona
Page 48:
2 Regulation of Conventional and No
Page 52:
Page 56:
Page 60:
Page 64:
Page 68:
Page 72:
Page 76:
26 P.M. Blumberg et al. 3.1 Introdu
Page 80:
28 P.M. Blumberg et al. 1981; Diamo
Page 84:
30 P.M. Blumberg et al. 3.4 DAG-Lac
Page 88:
32 P.M. Blumberg et al. 3.6 Role of
Page 92:
34 P.M. Blumberg et al. Interesting
Page 96:
36 P.M. Blumberg et al. the proximi
Page 100:
38 P.M. Blumberg et al. 3.14 C1 Dom
Page 104:
40 P.M. Blumberg et al. the A and B
Page 108:
42 P.M. Blumberg et al. The above r
Page 112:
44 P.M. Blumberg et al. 3.19 Role o
Page 116:
46 P.M. Blumberg et al. 3.20 Conclu
Page 120:
48 P.M. Blumberg et al. Churchill,
Page 124:
50 P.M. Blumberg et al. the isoster
Page 128:
52 P.M. Blumberg et al. Pu, Y., Pea
Page 132:
Chapter 4 Diacylglycerol Signaling:
Page 136:
4 Diacylglycerol Signaling OH O P D
Page 140:
4 Diacylglycerol Signaling intermed
Page 144:
4 Diacylglycerol Signaling cPKC (α
Page 148:
4 Diacylglycerol Signaling 4.3 DAG
Page 152:
4 Diacylglycerol Signaling DGKα DG
Page 156:
4 Diacylglycerol Signaling the spat
Page 160:
4 Diacylglycerol Signaling adhesion
Page 164:
4 Diacylglycerol Signaling prolifer
Page 168:
4 Diacylglycerol Signaling Gomez-Me
Page 172:
4 Diacylglycerol Signaling Maruyama
Page 176:
4 Diacylglycerol Signaling Cepsilon
Page 180:
Chapter 5 Regulation of PKC by Prot
Page 184:
5 Regulation of PKC by Protein-Prot
Page 188:
Page 192:
Page 196:
Page 200:
Page 204:
Page 208:
Page 212:
Page 216:
Page 220:
Page 224:
Page 228:
Page 232:
Chapter 6 Introduction: PKC Isozyme
Page 236:
6 Introduction: PKC Isozymes in the
Page 240:
Page 244:
Page 248:
Page 252:
118 E. Rozengurt Keywords Protein k
Page 256:
120 E. Rozengurt The initial descri
Page 260:
122 E. Rozengurt mechanisms, involv
Page 264:
124 E. Rozengurt PKC DAG DAG P Ser
Page 268:
126 E. Rozengurt Each translocation
Page 272:
128 E. Rozengurt multisite phosphor
Page 276:
130 E. Rozengurt Table 7.1. Identif
Page 280:
132 E. Rozengurt gastrointestinal p
Page 284:
134 E. Rozengurt receptor for bacte
Page 288:
136 E. Rozengurt (Zhang et al. 2005
Page 292:
138 E. Rozengurt PKD-mediated phosp
Page 296:
140 E. Rozengurt Clearly, more expe
Page 300:
142 E. Rozengurt In conclusion, stu
Page 304:
144 E. Rozengurt Doppler, H., Storz
Page 308:
146 E. Rozengurt Johannes, F. J., P
Page 312:
148 E. Rozengurt Mellor, H., & Park
Page 316:
150 E. Rozengurt Rey, O., Yuan, J.,
Page 320:
152 E. Rozengurt Van Lint, J. V., S
Page 324:
154 E. Rozengurt Zugaza, J. L., Sin
Page 328:
156 J.D. Black Keywords PKC • Cel
Page 332:
158 J.D. Black A and B (Malumbres a
Page 336:
160 J.D. Black epithelial cells sti
Page 340:
162 J.D. Black Fig. 8.1 Model of th
Page 344:
164 J.D. Black the ERK/MAPK signali
Page 348:
166 J.D. Black inhibit cyclin D1 ex
Page 352:
168 J.D. Black Fig. 8.2 Model of PK
Page 356:
170 J.D. Black hindered by the fact
Page 360:
172 J.D. Black of murine and human
Page 364:
174 J.D. Black in these cells (Balc
Page 368:
176 J.D. Black Fig. 8.3 The timing
Page 372:
178 J.D. Black Alisi, A., Spagnuolo
Page 376:
180 J.D. Black Classon, M., & Dyson
Page 380:
182 J.D. Black Hocevar, B. A., Morr
Page 384:
184 J.D. Black Nakagawa, S., Fujii,
Page 388:
186 J.D. Black Soh, J. W., & Weinst
Page 392:
188 J.D. Black Zhou, W., Takuwa, N.
Page 396:
190 M.E. Reyland and A.P. Bradford
Page 400:
Page 404:
Page 408:
Page 412:
Page 416:
Page 420:
Page 424:
Page 428:
Page 432:
Page 436:
Page 440:
Page 444:
Page 448:
Page 452:
Page 456:
Page 460:
Page 464:
224 M.T. Diaz-Meco and J. Moscat Li
Page 468:
226 M.T. Diaz-Meco and J. Moscat IK
Page 472:
228 M.T. Diaz-Meco and J. Moscat Co
Page 476:
230 M.T. Diaz-Meco and J. Moscat Th
Page 480:
232 M.T. Diaz-Meco and J. Moscat Th
Page 484:
234 M.T. Diaz-Meco and J. Moscat 10
Page 488:
236 M.T. Diaz-Meco and J. Moscat et
Page 492:
238 M.T. Diaz-Meco and J. Moscat et
Page 496:
240 M.T. Diaz-Meco and J. Moscat Du
Page 500:
242 M.T. Diaz-Meco and J. Moscat Ma
Page 504:
244 M.T. Diaz-Meco and J. Moscat Wo
Page 508:
Chapter 11 Introduction: PKC and Ca
Page 512:
11 Introduction: PKC and Cancer The
Page 516:
11 Introduction: PKC and Cancer Sun
Page 520:
254 K. Yoshida undergo apoptosis is
Page 524:
256 K. Yoshida on Ataxia telangiect
Page 528:
258 K. Yoshida induction of p53 (Ma
Page 532:
260 K. Yoshida Oda et al. 2000; Tai
Page 536:
262 K. Yoshida Brodie, C., & Blumbe
Page 540:
264 K. Yoshida Niedel, J. E., Kuhn,
Page 544:
Chapter 13 PKCs as Mediators of the
Page 548:
13 PKCs as Mediators of the Hedgeho
Page 552:
Page 556:
Page 560:
Page 564:
Page 568:
Page 572:
Page 576:
Page 580:
Page 584:
Chapter 14 PKC-PKD Interplay in Can
Page 588:
14 PKC-PKD Interplay in Cancer 14.2
Page 592:
14 PKC-PKD Interplay in Cancer in d
Page 596:
14 PKC-PKD Interplay in Cancer ERK1
Page 600:
14 PKC-PKD Interplay in Cancer acti
Page 604:
14 PKC-PKD Interplay in Cancer VEGF
Page 608:
14 PKC-PKD Interplay in Cancer Bude
Page 612:
14 PKC-PKD Interplay in Cancer Mart
Page 616:
14 PKC-PKD Interplay in Cancer Wein
Page 620:
306 A.K. Verma 15.1 Introduction Kn
Page 624:
308 A.K. Verma a Ehe I Eco RI Eco R
Page 628:
310 A.K. Verma 15.2.2.3 PKCe Transg
Page 632:
312 A.K. Verma when p53 has been mu
Page 636:
314 A.K. Verma the YXXC motif in G-
Page 640:
316 A.K. Verma UVR-induced release
Page 644:
318 A.K. Verma References Abe, K.,
Page 648:
320 A.K. Verma Lavker, R. M., & Sun
Page 652:
Chapter 16 PKC Isozymes and Skin Ca
Page 656:
16 PKC Isozymes and Skin Cancer act
Page 660:
16 PKC Isozymes and Skin Cancer (He
Page 664:
16 PKC Isozymes and Skin Cancer age
Page 668:
16 PKC Isozymes and Skin Cancer PKC
Page 672:
16 PKC Isozymes and Skin Cancer alt
Page 676:
16 PKC Isozymes and Skin Cancer Den
Page 680:
16 PKC Isozymes and Skin Cancer Ref
Page 684:
16 PKC Isozymes and Skin Cancer Deu
Page 688:
16 PKC Isozymes and Skin Cancer Kas
Page 692:
16 PKC Isozymes and Skin Cancer Red
Page 696:
16 PKC Isozymes and Skin Cancer alp
Page 700:
348 S.D. Merajver et al. 17.2 Mamma
Page 704:
350 S.D. Merajver et al. is that th
Page 708: 352 S.D. Merajver et al. perhaps du
Page 712: 354 S.D. Merajver et al. for some o
Page 716: 356 S.D. Merajver et al. agents in
Page 720: 358 S.D. Merajver et al. Kiley, S.
Page 724: 360 S.D. Merajver et al. Williams,
Page 728: 362 J. Kim and M.G. Kazanietz 28,00
Page 732: 364 J. Kim and M.G. Kazanietz Table
Page 736: 366 J. Kim and M.G. Kazanietz Signa
Page 740: 368 J. Kim and M.G. Kazanietz in an
Page 744: 370 J. Kim and M.G. Kazanietz AFAP-
Page 748: 372 J. Kim and M.G. Kazanietz DNA G
Page 752: 374 J. Kim and M.G. Kazanietz Aziz,
Page 756: 376 J. Kim and M.G. Kazanietz Linde
Page 762: Chapter 19 Protein Kinase C and Lun
Page 766: 19 Protein Kinase C and Lung Cancer
Page 806: Chapter 20 Introduction Patricia S.
Page 810:
20 Introduction The first compound
Page 814:
20 Introduction Tamaoki, T., & Naka
Page 818:
410 A. Basu DNA. Because chemothera
Page 822:
412 A. Basu to doxorubicin was asso
Page 826:
414 A. Basu PKC in vitro (Chambers
Page 830:
416 A. Basu decreasing the levels o
Page 834:
418 A. Basu of cisplatin-sensitive
Page 838:
420 A. Basu 21.3.4 Mechanism of PKC
Page 842:
422 A. Basu In contrast, PKCi but n
Page 846:
424 A. Basu Brodie, C., & Blumberg,
Page 850:
426 A. Basu Higgins, C. F. (1993).
Page 854:
428 A. Basu Pulaski, L., Szemraj, J
Page 858:
Chapter 22 PKCd as a Target for Che
Page 862:
22 PKCd as a Target for Chemotherap
Page 866:
Page 870:
Page 874:
Page 878:
Page 882:
Page 886:
Page 890:
Page 894:
Page 898:
Page 902:
Page 906:
456 V. Justilien and A.P. Fields fa
Page 910:
458 V. Justilien and A.P. Fields By
Page 914:
460 V. Justilien and A.P. Fields In
Page 918:
462 V. Justilien and A.P. Fields en
Page 922:
464 V. Justilien and A.P. Fields A
Page 926:
466 V. Justilien and A.P. Fields sm
Page 930:
468 V. Justilien and A.P. Fields PK
Page 934:
470 V. Justilien and A.P. Fields 23
Page 938:
472 V. Justilien and A.P. Fields in
Page 942:
474 V. Justilien and A.P. Fields pr
Page 946:
476 V. Justilien and A.P. Fields un
Page 950:
478 V. Justilien and A.P. Fields Ad
Page 954:
480 V. Justilien and A.P. Fields Go
Page 958:
482 V. Justilien and A.P. Fields Mu
Page 962:
484 V. Justilien and A.P. Fields Wa
Page 966:
486 Index Apoptotic effectors, 192
Page 970:
488 Index Cell survival (cont.) pro
Page 974:
490 Index Lung cancer (cont.) physi
Page 978:
492 Index Proliferation and cell-cy
Page 982:
494 Index Tumor suppression and pro
show all

Diacylglycerol Signaling

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?